0.72
+0.0062(+0.87%)
Currency In USD
| Previous Close | 0.72 |
| Open | 0.72 |
| Day High | 0.76 |
| Day Low | 0.71 |
| 52-Week High | 2.74 |
| 52-Week Low | 0.36 |
| Volume | 868,256 |
| Average Volume | 2M |
| Market Cap | 89.61M |
| PE | -0.63 |
| EPS | -1.19 |
| Moving Average 50 Days | 0.75 |
| Moving Average 200 Days | 0.82 |
| Change | 0.03 |
Invivyd Announces Positive Full Phase 1/2 Clinical Data for VYD2311, a Next Generation COVID-19 Monoclonal Antibody for Potential Use as a Non-Vaccine Preventative and for Treatment of Active Infection
GlobeNewswire Inc.
Jun 26, 2025 11:01 AM GMT
Attractive safety profile demonstrated across all dosing cohorts and routes of administration (IV, SC, and IM); all reported adverse events (AEs) deemed unrelated or classified as mild to moderate and largely related to injection site and infusion re
Invivyd Announces Publication of Landmark CANOPY Phase 3 PEMGARDA® (pemivibart) Clinical Trial; Results Underscore Strong Efficacy of Monoclonal Antibodies in Preventing COVID-19 in a Modern U.S. Population Against Relevant, Immune-Evasive SARS-CoV-2 Virus
GlobeNewswire Inc.
May 27, 2025 11:01 AM GMT
CANOPY assessed pemivibart safety and tolerability, antiviral immunobridging, and exploratory efficacy against COVID-19, and is the only clinical trial of an authorized or approved COVID-19 monoclonal antibody or vaccine with placebo-controlled clini
Invivyd Announces Inclusion of PEMGARDA® (pemivibart) in National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for B-Cell Lymphomas
GlobeNewswire Inc.
May 23, 2025 11:01 AM GMT
WALTHAM, Mass., May 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), today announced that PEMGARDA® (pemivibart), its investigational monoclonal antibody, has been added to the National Comprehensive Cancer Network® (NCCN®) Clinical Pract
If you invested $1000 in Invivyd, Inc. (IVVD) since IPO date, it would be worth $35.78 as of July 01, 2025 at a share price of $0.747. Whereas If you bought $1000 worth of Invivyd, Inc. (IVVD) shares 3 years ago, it would be worth $213.43 as of July 01, 2025 at a share price of $0.747.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
